ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) notified on Thursday a Rs3,564 cut in the price of Remdesivir, a drug found to be effective in treating patients hospitalised with coronavirus.
According to the notification, the new price of 100mg vial of the antiviral is fixed at Rs5,680.
Also Read: WHO advises against remdesivir for all hospitalised COVID-19 patients
The drug regulator has asked firms importing Remesivir to mention the drug price on its packet.
On November 27, the federal cabinet had green-lighted a cut in the price of the antiviral.
Also Read: ‘NCOC finalised recommendations for procurement of COVID-19 vaccine’
Earlier, the Drug Regulatory Authority of Pakistan (DRAP) had suggested a 38 per cent cut in 100 mg Remdesivir injection price and recommended fixing the rate at Rs5,680. A summary to this effect was sent to the federal cabinet by the health ministry for approval.
